A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder

NCT07677384 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: HS-10506

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.